Improved detection of resistance at failure to a tenofovir, emtricitabine and efavirenz regimen by ultradeep sequencing.
E Todesco,
Christophe RODRIGUEZ,
L Morand-Joubert,
Mélanie MERCIER-DARTY,
N Desire,
M Wirden,
PM Girard,
C Katlama,
V Calvez,
AG Marcelin,
J antimicrob Chemother. 01/05/2015;70(5) : 1503-1506 10.1093/jac/dku557. 21/01/2015
Liver resection for hepatocellular carcinoma in 313 Western patients: tumor biology and underlying liver rather than tumor size drive prognosis.
MD Kluger,
J Salceda,
A Laurent,
C Tayar,
C Duvoux,
T Decaens,
Alain LUCIANI,
JT Van nhieu,
D Azoulay,
D Cherqui,
J Hepatol 01/05/2015;62(5) : 1131-1140 10.1016/j.jhep.2014.12.018. 18/12/2014
Efficacy and safety of simeprevir with PegIFN/ribavirin in naïve or experienced patients infected with chronic HCV genotype 4.
C Moreno,
Christophe HEZODE,
P Marcellin,
S Bourgeois,
S Francque,
D Samuel,
F Zoulim,
JD Grange,
U Shukla,
O Lenz,
S Ouwerkerk-Mahadevan,
B Fevery,
M Peeters,
M Beumont,
W Jessner,
J Hepatol 01/05/2015;62(5) : 1047-1055 10.1016/j.jhep.2014.12.031 17/01/2015
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.
K Schulze,
S Imbeaud,
E Letouze,
LB Alexandrov,
Julien CALDERARO,
S Rebouissou,
G Couchy,
C Meiller,
J Shinde,
F Soysouvanh,
R Pinyol,
L Pelletier,
C Balabaud,
A Laurent,
JF Blanc,
V Mazzaferro,
F Calvo,
A Villanueva,
JC Nault,
P Bioulac-Sage,
MR Stratton,
JM Llovet,
J Zucman-Rossi,
Nat Genet 01/05/2015;47(5) : 505-511 10.1038/ng.3252 30/03/2015
Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver.
X Li,
J Tao,
A Cigliano,
M Sini,
Julien CALDERARO,
D Azoulay,
C Wang,
Y Liu,
L Jiang,
K Evert,
MI Demartis,
S Ribback,
K Utpatel,
F Dombrowski,
M Evert,
DF Calvisi,
X Chen,
Oncotarget 30/04/2015;6(12) : 10102-15 .
Protein-peptide arrays for detection of specific anti-hepatitis D virus (HDV) genotype 1, 6, and 8 antibodies among HDV-infected patients by surface plasmon resonance imaging
MB Villiers,
JC Cortay,
S Cortes,
B Bloquel,
Ségolène BRICHLER,
C Brakha,
A Kay,
N Falah,
F Zoulim,
C Marquette,
PN Marche,
P Deny,
J Clin Microbiol. 01/04/2015;53(4) : 1164-1171 10.1128/JCM.03002-14. 28/01/2015
Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a rando
M Sulkowski,
Christophe HEZODE,
J Gerstoft,
JM Vierling,
J Mallolas,
S Pol,
M Kugelmas,
A Murillo,
N Weis,
R Nahass,
O Shibolet,
L Serfaty,
M Bourliere,
E DeJesus,
E Zuckerman,
F Dutko,
M Shaughnessy,
P Hwang,
AY Howe,
J Wahl,
M Robertson,
E Barr,
B Haber,
Lancet 21/03/2015;385(9973) : 1087-1097 10.1016/S0140-6736(14)61793-1. 11/11/2014
